Form 144: 113,000 APH shares via Morgan Stanley, acquired by option exercise
Rhea-AI Filing Summary
Amphenol Corporation (APH) Form 144 notice reports a proposed sale of 113,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $12,304,750.80 and an approximate sale date of 08/08/2025. The shares were acquired on 08/08/2025 by exercising options under a registered plan and were to be paid in cash. The filing records total shares outstanding of 1,220,921,111 for the issuer. The document also discloses a prior sale of 160,000 shares on 05/30/2025 that generated gross proceeds of $14,326,512.00. The seller affirms no knowledge of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider proposes an option-exercise sale of 113,000 APH shares; size is small relative to total shares outstanding.
The filing shows an insider liquidity event tied to an option exercise with proceeds paid in cash and executed through Morgan Stanley Smith Barney. The proposed block equals 113,000 shares with an aggregate market value of $12,304,750.80, against reported outstanding shares of 1,220,921,111. A disclosed prior sale of 160,000 shares on 05/30/2025 produced gross proceeds of $14,326,512.00. From a financial-materiality perspective, the sizes reported are small relative to the issuer's share base, so the immediate market impact appears limited.
TL;DR: Form 144 documents a planned sale under Rule 144 with the seller attesting no undisclosed material adverse information.
The notice identifies the broker as Morgan Stanley Smith Barney and specifies that the securities were acquired via exercise of options under a registered plan and were to be paid in cash. The filing includes the standard seller representation that they do not possess material nonpublic information. This record is a routine compliance disclosure under Rule 144 and signals adherence to required notification procedures rather than a governance event implying material change.
FAQ
Who is identified as the seller or prior seller in the Form 144 for Amphenol (APH)?
How many Amphenol (APH) shares are proposed to be sold and what is their market value?
When were the shares acquired and how were they paid for according to the filing?
Which broker is handling the proposed sale of APH shares?
Does the filing disclose any recent sales of APH shares by the person for whose account the securities are to be sold?
Does the seller assert knowledge of undisclosed material adverse information in the filing?